Overall, our studies suggested that Drp1 inhibition is a promising therapy to reduce excessive mitochondrial fission, increase mitochondrial fusion, and maintain mitochondrial function in neurons affected by PD. This evidence concerns the gene DNM1L and Parkinson disease.